• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        K-rasRibozyme for Lung Cancer

        互联网

        1136
        Mutations in the K-ras oncogene and mutations or deletions in the tumor suppressor gene p53 are the two most prevalent oncogenetic alterations in human lung cancer. Ras mutations occur primarily in lung adenocarcinomas and small numbers of large cell undifferentiated and squamous cell lung carcinomas, but have not been detected in small cell lung carcinomas. Approximately 30% of lung adenocarcinomas carry a ras mutation. In US and European studies, nearly all mutations occur in the K-ras gene, although N-ras and H-ras mutations have been detected occasionally (1 ). K-ras mutations occur predominantly in codon 12 with a G→T transversion (Table 1 ).
        Table 1  K- ras Mutations and Potential Ribozyme Substrate Sites for Adenocarcinoma and Large Cell Carcinoma of the Lung

        Mutation

        Codon

        Sequence

        Corresponding ribozyme substrate sequence

        % of total mutation

        12

        TGT

        UGU

        55

        12

        GAT

        GAU

        18

        12

        GTT

        GUU

        12

        12

        GCT

        GCU

        3

        12

        AGT

        AGU

        3

        12

        TTT

        UUU

        3

        13

        TGC

        UGC

        6

        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序